Shire PLC (NASDAQ:SHPG)
During the Trading Day
| 96.94 |  +1.66 / +1.74% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 97.01 | +0.07 / +0.07% |
Volume: 30.8K |
Latest SHPG News | Press Releases
| Shire Rises On Unusually High Volume (SHPG) May 20 / TheStreet.com | 5 Drugs Stocks On The Rise May 20 / TheStreet.com |
Today’s Trading
| Previous close | 95.28 |
| Today’s open | 95.42 |
| Day’s range | 95.42 - 97.24 |
| Volume | 946,841 |
| Average volume (3 months) | 587,885 |
| Market cap | $17.6B |
| Dividend yield | 0.54% |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -14.55% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | +9.69% |
| P/E ratio | NM |
| Price/Sales | 3.64 |
| Price/Book | 4.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | +2.09 | +2.70% |
| ACTActavis Inc | +3.05 | +2.40% |
| ZTSZoetis Inc | -0.67 | -1.99% |
| ALXNAlexion Pharmaceutic... | +2.64 | +2.64% |
Data as of 4:01pm ET, 05/21/2013
Financials
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.64 |
| Annual revenue (last year) | $4.7B |
| Annual profit (last year) | $746.8M |
| Net profit margin | 15.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Flemming Ørnskov, MD, MBA |
CFO, Director, CAO & Investor Relations Contact Graham C. Hetherington |
Corporate headquarters Dublin, -- |
Forecasts
